[Experiences with the new vasotherapeutic drug Trental in dermatology].
D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D005260:Female; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D007659:Ketones / Q000627:therapeutic use; D007866:Leg / Q000098:blood supply; D007871:Leg Ulcer / Q000188:drug therapy; D008297:Male; D013924:Thrombophlebitis / Q000188:drug therapy; D014652:Vascular Diseases / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014970:Xanthines / Q000627:therapeutic use*
D007659:Ketones; D014665:Vasodilator Agents; D014970:Xanthines
Erfahrungen mit dem neuen Vasotherapeutikum Trental in der dermatologischen Fachpraxis.